IP Library Granted Patent US 10,835,461
Granted Patent B2
US 10,835,461 · App. 15/780,041 · Granted Nov 17, 2020

Bio-active material composite, preparing method thereof and cosmetic composition containing the same

Inventors: Bae Yong Kim (Seoul, KR); Jai Soon Myung (Chuncheon-si, KR); Ji Yeon Roh (Seongnam-si, KR)
Assignee: Bae Yong Kim
A61K8/19A61K8/0254A61K8/347A61K8/361A61K8/365A61K8/368A61K8/498A61K8/4953A61K8/4986A61K8/64A61K8/671A61K8/676A61Q19/02A61Q19/08A61K2800/522A61K2800/592A61K2800/74
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,835,461
App. No.
15/780,041
Granted
Nov 17, 2020
Kind
B2
Abstract

Provided is a composite containing bio-active material stably combined with a rare-earth hydroxide compound having a layered structure. The bio-active materials in the composite are preserved in terms of long-term stability at high temperature of 50° C. or above and the composite maintained in the neutral pH condition to minimize side effects like latent toxicity, irritations, etc. Further, the present invention is useful for a skin-whitening, anti-wrinkle, or anti-aging cosmetic composition containing the composite.

Claims (42)

1. A composite containing a bio-active material combined with a rare-earth hydroxide compound, wherein the composite is represented by the following chemical formula 1:

[RE(OH) 3−x .y H 2 O].[A n ] x/n .[B] 2   [Chemical Formula 1]

wherein RE is at least one or more rare-earth element selected from the group consisting of yttrium (Y), gadolinium (Gd) and europium (Eu); A is an anion selected from the group consisting of F − , Cl − , ClO 3 − , ClO 4 − , Br − , BrO 3 − , IO 3 − , IO 4 − , I 3 − , OH − , CO 3 2− , HCO 3 − , NO 3 − , SO 4 2− , PO 4 3− , HPO 4 2 , and H 2 PO 4 − ; y is greater than zero, that is, 0<y; n is the charge number of the anion; x is greater than 0 and less than 3, that is, 0<x<3; B is a bio-active material; and z is greater than zero, that is, 0<z;

wherein the rare-earth hydroxide compound has a layered structure; and

wherein the bio-active material is at least one or more selected from the group consisting of vitamin C, vitamin A, salicylic acid, kojic acid, alpha-lipoic acid, ellagic acid, resveratrol, caffeine, docosahexaenoic acid, eicosapentaenoic acid, linoleic acid and glutathione.

2. The composite as claimed in claim 1 , wherein

the bio-active material comprises Vitamin C; and

the rare-earth hydroxide compound comprises yttrium hydroxide.

3. The composite as claimed in claim 1 , wherein

the bio-active material comprises Vitamin C; and

the rare-earth hydroxide compound comprises gadolinium/europium hydroxide.

4. The composite as claimed in claim 1 , wherein

the bio-active material comprises Vitamin A; and

the rare-earth hydroxide compound comprises yttrium hydroxide.

5. The composite as claimed in claim 1 , wherein

the bio-active material comprises salicylic acid; and

the rare-earth hydroxide compound comprises yttrium hydroxide.

6. The composite as claimed in claim 1 , wherein

the bio-active material comprises kojic acid; and

the rare-earth hydroxide compound comprises yttrium hydroxide.

7. The composite as claimed in claim 1 , wherein

the bio-active material comprises alpha-lipoic acid; and

the rare-earth hydroxide compound comprises yttrium hydroxide.

8. The composite as claimed in claim 1 , wherein

the bio-active material comprises ellagic acid; and

the rare-earth hydroxide compound comprises yttrium hydroxide.

9. The composite as claimed in claim 1 , wherein

the bio-active material comprises resveratrol; and

the rare-earth hydroxide compound comprises yttrium hydroxide.

10. The composite as claimed in claim 1 , wherein

the bio-active material comprises docosahexaenoic acid; and

the rare-earth hydroxide compound comprises yttrium hydroxide.

11. The composite as claimed in claim 1 , wherein

the bio-active material comprises eicosapentaenoic acid; and

the rare-earth hydroxide compound comprises yttrium hydroxide.

12. The composite as claimed in claim 1 , wherein

the bio-active material comprises linoleic acid; and

the rare-earth hydroxide compound comprises yttrium hydroxide.

13. The composite as claimed in claim 1 , wherein

the bio-active material comprises glutathione; and

the rare-earth hydroxide compound comprises yttrium hydroxide.

14. The composite as claimed in claim 1 , wherein RE is Y.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2018
From: KIM, BAE YONG; MYUNG, JAI SOON; ROH, JI YEON
To: KIM, BAE YONG
Reel/Frame 045936/0380 →
Priority Claims (1)
KR 10-2015-0170124 · Dec 1, 2015 · national
Continuity (1)
Related Publication 20180369084A1 · Dec 27, 2018